Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system

Mayo Clinic Proceedings

Volumn 80, Issue 10, 2005, Pages 1326-1338

  Benarroch, Eduardo E ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; AMMONIA; AQUAPORIN; ARGIPRESSIN; BICARBONATE; CALCIUM ION; CARBONATE DEHYDRATASE; CHLORIDE ION; CONNEXIN 43; CYSTINE; EXCITATORY AMINO ACID TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCOGEN; INOSITOL TRISPHOSPHATE; INWARDLY RECTIFYING POTASSIUM CHANNEL; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; MONOCARBOXYLATE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; POTASSIUM ION; SODIUM ION; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL INTERACTION; CELL VOLUME; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; DEGENERATIVE DISEASE; ENERGY METABOLISM; EXTRACELLULAR SPACE; GAP JUNCTION; GLIOMA; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMAN; HYPEREMIA; MIGRAINE; NERVE CELL; NEUROPROTECTION; OXIDATIVE STRESS; PH; SEIZURE; SYNAPTIC TRANSMISSION;

EID: 25844440561     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.10.1326     Document Type: Conference Paper

References (83)

1. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003;26:523-530.
2. Kacem K, Lacombe P, Seylaz J, Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: a confocal microscopy study. Glia. 1998;23:1-10.
3. Olson JE, Li GZ, Wang L, Lu L. Volume-regulated anion conductance in cultured rat cerebral astrocytes requires calmodulin activity. Glia. 2004;46:391-401.
4. MacAulay N, Hamann S, Zeuthen T. Water transport in the brain: role of cotransporters. Neuroscience. 2004;129:1031-1044.
5. Giaume C, McCarthy KD. Control of gap-junctional communication in astrocytic networks. Trends Neurosci. 1996;19:319-325.
6. Bennett MV, Contreras JE, Bukauskas FF, Saez JC. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci. 2003;26:610-617.
7. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987;325:253-257.
8. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002;200:629-638.
9. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496-497.
10. Bezzi P, Domercq M, Vesce S, Volterra A. Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog Brain Res. 2001;132:255-265.
11. Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 2003;26:536-542.
12. Haydon PG. GLIA: listening and talking to the synapse. Nat Rev Neurosci. 2001;2:185-193.
13. Hertz L, Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004;27:735-743.
14. Verkhratsky A, Steinhauser C. Ion channels in glial cells. Brain Res Brain Res Rev. 2000;32:380-412.
15. Verkhratsky A, Kettenmann H. Calcium signalling in glial cells. Trends Neurosci. 1996;19:346-352.
16. Simard M, Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience. 2004;129:877-896.
17. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 1994;263:1768-1771.
18. Baranano DE, Ferris CD, Snyder SH. Atypical neural messengers. Trends Neurosci. 2001;24:99-106.
19. Amara SG, Fontana AC. Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int. 2002;41:313-318.
20. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
21. Sonnewald U, Qu H, Aschner M. Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J Pharmacol Exp Ther. 2002;301:1-6.
22. Magistretti PJ, Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci. 1999;14:177-182.
23. +-mediated metabolic waves. Proc Natl Acad Sci USA. 2004;101:14937-14942.
24. Marcaggi P, Coles JA. Ammonium in nervous tissue: transport across cell membranes, fluxes from neurons to glial cells, and role in signalling [published correction appears in Prog Neurobiol. 2001;65:209-210]. Prog Neurobiol. 2001;64:157-183.
25. Suarez I, Bodega G, Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochem Int. 2002;41:123-142.
26. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000;62:649-671.
27. Chatton JY, Pellerin L, Magistretti PJ. GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission. Proc Natl Acad Sci USA. 2003;100:12456-12461.
28. Chih CP, Lipton P, Roberts EL Jr. Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci. 2001;24:573-578.
29. Leybaert L. Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J Cereb Blood Flow Metab. 2005;25:2-16.
30. Brown AM. Brain glycogen re-awakened. J Neurochem. 2004;89:537-552.
31. McCall AL. Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol. 2004;490:147-158.
32. Deitmer JW. Strategies for metabolic exchange between glial cells and neurons. Respir Physiol. 2001;129:71-81.
33. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience. 2004;129:1045-1056.
34. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci. 2003;4:991-1001.
35. Jackson PS, Madsen JR. Identification of the volume-sensitive organic osmolyte/anion channel in human glial cells. Pediatr Neurosurg. 1997;27:286-291.
36. Hussy N, Deleuze C, Desarmenien MG, Moos FC. Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol. 2000;62:113-134.
37. Gunnarson E, Zelenina M, Aperia A. Regulation of brain aquaporins. Neuroscience. 2004;129:947-955.
38. Connors NC, Adams ME, Froehner SC, Kofuji P. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via α-syntrophin in glia. J Biol Chem. 2004;279:28387-28392.
39. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5:347-360.
40. Anderson CM, Nedergaard M. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci. 2003;26:340-344.
41. Mintun MA, Vlassenko AG, Rundle MM, Raichle ME. Increased lactate/pyruvate ratio augments blood flow in physiologically activated human brain. Proc Natl Acad Sci U S A. 2004;101:659-664.
42. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci. 2003;6:43-50.
43. Harder DR, Zhang C, Gebremedhin D. Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci. 2002;17:27-31.
44. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53-97.
45. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61:657-668.
46. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38:73-84.
47. Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother. 2004;58:39-46.
48. Sonkusare SK, Kaul CL, Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope. Pharmacol Res. 2005;51:1-17.
49. Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci. 1998;19:328-334.
50. Barbeito LH, Pehar M, Cassina P, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev. 2004;47:263-274.
51. Rao SD, Weiss JH. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci. 2004;27:17-23.
52. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med. 2004;4:193-205.
53. McBean GJ. Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci. 2002;23:299-302.
54. Sontheimer H. Malignant gliomas: perverting glutamate and ion homeo-stasis for selective advantage. Trends Neurosci. 2003;26:543-549.
55. Mollace V, Nottet HS, Clayette P, et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 2001;24:411-416.
56. Blum D, Torch S, Lambeng N, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001;65:135-172.
57. Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Brain Res Rev. 2000;32:215-234.
58. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24(suppl 2):2-7.
59. Sanchez-del-Rio M, Reuter U. Migraine aura: new information on underlying mechanisms. Curr Opin Neurol. 2004;17:289-293.
60. Nedergaard M, Cooper AJ, Goldman SA. Gap junctions are required for the propagation of spreading depression. J Neurobiol. 1995;28:433-444.
61. Montagna P. The physiopathology of migraine: the contribution of genetics. Neurol Sci. 2004;25(suppl 3):S93-S96.
62. Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17-24.
63. Marconi R, De Fusco M, Aridon P, et al. Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol. 2003;53:376-381.
64. Steinhauser C, Seifert G. Glial membrane channels and receptors in epilepsy: impact for generation and spread of seizure activity. Eur J Pharmacol. 2002;447:227-237.
65. D'Ambrosio R. The role of glial membrane ion channels in seizures and epileptogenesis. Pharmacol Ther. 2004;103:95-108.
66. Fonseca CG, Green CR, Nicholson LF. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res. 2002;929:105-116.
67. + homeostasis in the human epileptogenic hippocampus. Proc Natl Acad Sci U S A. 2005;102:1193-1198.
68. Kimelberg HK. Water homeostasis in the brain: basic concepts. Neuroscience. 2004;129:851-860.
69. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat. 2002;200:639-646.
70. Saadoun S, Papadopoulos MC, Davies DC, Bell BA, Krishna S. Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer. 2002;87:621-623.
71. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience. 2004;129:1021-1029.
72. Klatzo I. Presidental address: neuropathological aspects of brain edema. J Neuropathol Exp Neurol. 1967;26:1-14.
73. + siphoning in brain contusion, bacterial meningitis, and brain tumours: immunohistochemical case review. J Clin Pathol. 2003;56:972-975.
74. Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H. Expression of voltage-gated chloride channels in human glioma cells. J Neurosci. 2003;23:5572-5582.
75. Da T, Verkman AS. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci. 2004;45:4477-4483.
76. Takahashi H, Hamada H, Teramoto A. Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema. Acta Neurochir Suppl. 2000;76:323-327.
77. Norenberg MD, Jayakumar AR, Rama Rao KV. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2004;19:313-329.
78. Vaquera J, Chung C, Blei AT. Brain edema in acute liver failure: a window to the pathogenesis of hepatic encephalopathy. Ann Hepatol. 2003;2:12-22.
79. Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int J Biochem Cell Biol. 2003;35:1175-1181.
80. Haussinger D, Schliess F, Kircheis G. Pathogenesis of hepatic encephalopathy. J Gastroenterol Hepatol. 2002; 17(suppl 3):S256-S259.
81. Butterworth RF. Molecular neurobiology of acute liver failure. Semin Liver Dis. 2003;23:251-258.
82. Ahboucha S, Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis. 2004;19:331-343.
83. Als-Nielsen B, Gluud LL, Gluud C. Benzodiazepine receptor antagonists for hepatic encephalopathy. Cochrane Database Syst Rev. 2004;2:CD002798.